India Approves AstraZeneca and local COVID vaccines
Saudi Press Agency
Sunday 1442/5/19 - 2021/01/03
New Delhi, January 3, 2021, SPA -- India's drugs regulator on Sunday gave final approval for the emergency-use of two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech and a state-run institute, Reuters reported.
The decisions mark the first vaccine approvals for the world's second-most populous country, which after the United States, has recorded the most infections of the coronavirus disease.
It is now expected to start a massive immunisation programme within about a week, a government official said, and hopes to inoculate 300 million of its 1.35 billion people free of charge in the first six to eight months of this year.
13:31 LOCAL TIME 10:31 GMT
|Join the GlobalSecurity.org mailing list|